Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

U.S. In Vitro Diagnostics Market with COVID-19 Impact Analysis, By Product, By Test Type, By Application, By End User and By Region - Size, Share, & Forecast from 2021-2027

Published by AnalystView Market Insights Product code 997996
Published Content info 234 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. In Vitro Diagnostics Market with COVID-19 Impact Analysis, By Product, By Test Type, By Application, By End User and By Region - Size, Share, & Forecast from 2021-2027
Published: March 1, 2021 Content info: 234 Pages
Description

REPORT HIGHLIGHT

The global U.S. In Vitro Diagnostics market was valued at USD 36.0 billion in 2020, growing with 5.0% CAGR during the forecast period, 2021-2027.

In-vitro diagnostics are the type of medical devices & consumables which are utilized to perform in vitro tests for various biological samples. The in-vitro diagnostic products can be reagents, instruments, or any system that is used for the diagnosis of disorders.

Market Dynamics

The U.S. in-vitro diagnostics market is estimated to witness significant growth in the next few years. The rapid demand for testing due to the COVID-19 pandemic is a key factor boosting the market growth. In addition, the growing trend of automated in-vitro diagnostic systems for laboratories & hospitals to provide accurate, efficient, and error-free diagnoses is expected to spur market growth. Further, the rising older adult population is also contributing to market growth. According to the United Nations, the number of individuals aged 80 years & above is projected to rise by threefold from 137.0 million in 2017 to 425.0 million by 2050. Thus, the increasing geriatric population with a chronic disorder is projected to foster the demand for in-vitro diagnostics.

Furthermore, the increasing surge of COVID-19 cases has significantly impelled the diagnostics industry into action, with a focus on developing novel and fast diagnostics kits for detection. Moreover, the rising prevalence of various diseases such as autoimmune diseases, cancer, and inflammatory conditions is expected to promote market growth. For example, according to the American Cancer Society, in 2018, around 1.70 million new cancer cases were registered.

The U.S. in-vitro diagnostics market is segmented into product, test type, application, and end-user segments. Based on product, the reagents segment held the largest revenue share of over 60.0% in 2019. By test type, the immunodiagnostics segment is estimated to dominate during the forecast period. By application, the infectious diseases segment held the largest revenue share in 2019.

Regional Insights

The increasing use of POC (Point-of-care) diagnostics, developed technologies, increasing awareness, and growing acceptance of personalized medicines is surging regional growth. The increasing government healthcare expenditure and higher prevalence of chronic disorders such as cancer, heart diseases, asthma, and diabetes, along with COVID -19 is augmenting the market growth in the U.S.

Competitive Landscape

The U.S. in vitro diagnostics industry is highly competitive in nature. The market is dominated by a few players including Becton, Dickinson and Company, Abbott Laboratories, and Danaher Corporation. Key companies are adopting strategies actions such as new product development, strategic mergers & acquisitions, and collaboration to expand their business. For instance, in January 2019, Abbott has acquired Cephea Valve Technologies Inc., a medical device company to expand its product portfolio.

Key features of the study:

This proposed research study on U.S. In Vitro Diagnostics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for U.S. In Vitro Diagnostics market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the U.S. In Vitro Diagnostics market

Impact of COVID-19 on U.S. In Vitro Diagnostics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on U.S. In Vitro Diagnostics market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the U.S. In Vitro Diagnostics market, we have also included competitive landscape and key innovator analysis for the U.S. In Vitro Diagnostics market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the U.S. In Vitro Diagnostics market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the U.S. In Vitro Diagnostics market on global as well as regional level.

The global U.S. In Vitro Diagnostics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET KEY PLAYERS

Abbott Laboratories

Becton, Dickinson and Company

Danaher Corporation

F. Hoffmann-La Roche Ltd.

BioMerieux SA

Sysmex Corporation

Bio Rad

Thermo Fisher Scientific Inc.

Qiagen

Siemens Healthcare GmbH

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT

Instruments

Reagents

Others

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET, BY TEST TYPE

Clinical Chemistry

Molecular Diagnostics

Immuno Diagnostics

Hematology

Others

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

Infectious Diseases

Cancer/Oncology

Cardiology

Autoimmune Diseases

Diabetes

Nephrology

Others

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER

Diagnostic Laboratories

Hospitals and Clinics

Others

GLOBAL U.S. IN VITRO DIAGNOSTICS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

Table of Contents

TABLE OF CONTENT

1. U.S. In Vitro Diagnostics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Product
    • 2.1.2. Market Snippet by Test Type
    • 2.1.3. Market Snippet by Application
    • 2.1.4. Market Snippet by End User
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. U.S. In Vitro Diagnostics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. U.S. In Vitro Diagnostics Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. U.S. In Vitro Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. U.S. In Vitro Diagnostics Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. U.S. In Vitro Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents
    • 7.1.4. Others

8. U.S. In Vitro Diagnostics Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2020 & 2027 (%)
  • 8.2. Clinical Chemistry
  • 8.3. Molecular Diagnostics
  • 8.4. Immuno Diagnostics
  • 8.5. Hematology
  • 8.6. Others

9. U.S. In Vitro Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
  • 9.2. Infectious Diseases
  • 9.3. Cancer/Oncology
  • 9.4. Cardiology
  • 9.5. Autoimmune Diseases
  • 9.6. Diabetes
  • 9.7. Nephrology
  • 9.8. Others

10. U.S. In Vitro Diagnostics Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2020 & 2027 (%)
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals and Clinics
  • 10.4. Others

11. U.S. In Vitro Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)

12. Key Vendor Analysis

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Becton, Dickinson and Company
    • 12.2.3. Danaher Corporation
    • 12.2.4. F. Hoffmann-La Roche Ltd.
    • 12.2.5. BioMerieux SA
    • 12.2.6. Sysmex Corporation
    • 12.2.7. Bio Rad
    • 12.2.8. Thermo Fisher Scientific Inc.
    • 12.2.9. Qiagen
    • 12.2.10. Siemens Healthcare GmbH

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE U.S. In Vitro Diagnostics market: Products Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Products
  • TABLE U.S. In Vitro Diagnostics market, by Products 2016-2027 (USD Million)
  • TABLE U.S. In Vitro Diagnostics market: Test Type Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE U.S. In Vitro Diagnostics market, by Test Type 2016-2027 (USD Million)
  • TABLE U.S. In Vitro Diagnostics market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE U.S. In Vitro Diagnostics market, by Region 2016-2027 (USD Million)
  • TABLE North America U.S. In Vitro Diagnostics market, by Country, 2016-2027 (USD Million)
  • TABLE North America U.S. In Vitro Diagnostics market, by Products, 2016-2027 (USD Million)
  • TABLE North America U.S. In Vitro Diagnostics market, by Test Type, 2016-2027 (USD Million)

List of Figures

  • FIGURE U.S. In Vitro Diagnostics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Product segment market share analysis, 2020 & 2027
  • FIGURE Product segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Test Type segment market share analysis, 2020 & 2027
  • FIGURE Test Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America U.S. In Vitro Diagnostics market share and leading players, 2019
  • FIGURE India U.S. In Vitro Diagnostics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
Back to Top